Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Phase 1 Trial Of Bone Marrow Stromal Cells (Bone Marrow-derived MSCS) To Treat Tissue Damage In Allogeneic Stem Cell Transplant Recipients: Biological Markers Correlate With Clinical Responses and Survival

Minoo Battiwalla, MD, MS, Fang Yin, MD, Sawa Ito, Xingmin Feng, PhD, Fariba Chinian, M.S., J. Joseph Melenhorst, PhD, Eleftheria K Koklanaris, BSN, Marianna Sabatino, David Stroncek, MD, Leigh Samsel, MS, Jeffrey K. Klotz, MD, Nancy F. Hensel, Pamela Robey, PhD, A. John Barrett, MD

Blood (2013) 122 (21): 3282.

https://doi.org/10.1182/blood.V122.21.3282.3282

Published: 2013

Journal Articles

Contrast Enhanced Cardiac CT Detects Coronary Artery Disease In 44% Of Asymptomatic Long-Term Adult Allogeneic Stem Cell Transplant Survivors

Natasha A Jain, MD, Marcus Y Chen, MD, Sujata Shanbhag, MD, Kit Lu, MD, Priyanka A Pophali, MD, Sawa Ito, Eleftheria K Koklanaris, BSN, Christopher S. Hourigan, MD, PhD, A. John Barrett, MD, Minoo Battiwalla, MD, MS

Blood (2013) 122 (21): 2080.

https://doi.org/10.1182/blood.V122.21.2080.2080

Published: 2013

Journal Articles

Post-Transplant Pulmonary Function Abnormalities Normalize in Survivors by the Second Decade After Allogeneic Stem Cell Transplantation

Natasha A Jain, MD, Eleftheria K. Koklanaris, BSN, Kamna Chawla, MD, MS, Priyanka A Pophali, MD, Jeffrey K. Klotz, MD, Christopher S. Hourigan, MD, PhD, Bipin N. Savani, MD, Sawa Ito, MD, A. John Barrett, MD, FRCP, Minoo Battiwalla, MD, MS

Blood (2012) 120 (21): 1967.

https://doi.org/10.1182/blood.V120.21.1967.1967

Published: 2012

Journal Articles

Second Stem Cell Transplantation (SCT) for Relapsed Leukemia Provides Only Modest Prolongation of Survival

Zachariah A. McIver, DO, Thomas Hughes, Pharm D, Sawa Ito, MD, Minoo Battiwalla, MD, MS, Eleftheria K. Koklanaris, BSN, Janice Haggerty, RN, Nancy F. Hensel, BS, A. John Barrett, MD

Blood (2011) 118 (21): 2001.

https://doi.org/10.1182/blood.V118.21.2001.2001

Published: 2011

Journal Articles

Chronic Graft Versus Host Disease (GVHD) Does Not Impact Cardiovascular Risk Factors in Survivors of Allogeneic Hematopoietic Stem Cell Transplantation (SCT) up to the Second Decade Post-Transplant,

Priyanka A Pophali, MD, Kamna Chawla, MD, MS, Eleftheria K. Koklanaris, BSN, Avan Antia, Simar Chawla, Sawa Ito, MD, Jeffrey K. Klotz, MD, Robert Q. Le, MD, PhD, A. John Barrett, MD, FRCP, Minoo Battiwalla, MD, MS

Blood (2011) 118 (21): 4099.

https://doi.org/10.1182/blood.V118.21.4099.4099

Published: 2011

Journal Articles

Impact of Tyrosine Kinase Inhibitor (TKI) in Chronic Myeloid Leukemia (CML) Relapsing After T Cell Depleted Allogeneic Stem Cell Transplantation (SCT)

Sawa Ito, MD, Minoo Battiwalla, MD, MS, Eleftheria K. Koklanaris, BSN, Jeanine Superata, Richard Childs, MD, A. John Barrett, MD

Blood (2011) 118 (21): 2762.

https://doi.org/10.1182/blood.V118.21.2762.2762

Published: 2011

Journal Articles

Evolution of the donor T-cell repertoire in recipients in the second decade after allogeneic stem cell transplantation

Robert Quan Le, J. Joseph Melenhorst, Minoo Battiwalla, Brenna Hill, Sarfraz Memon, Bipin N. Savani, Aarthi Shenoy, Nancy F. Hensel, Eleftheria K. Koklanaris, Keyvan Keyvanfar, Frances T. Hakim, Daniel C. Douek, A. John Barrett

Blood (2011) 117 (19): 5250–5256.

https://doi.org/10.1182/blood-2011-01-329706

Published: 2011

Journal Articles

4-Log Ex-Vivo T-Lymphocyte Depleted Myeloablative HLA-Matched Sibling Transplants; a Platform for Adoptive Immunotherapy

Minoo Battiwalla, MD, MS, Zachariah A. McIver, DO, Janice Haggerty, Eleftheria K. Koklanaris, BS, Kamna Chawla, MD, MS, Jeanine Superata, Richard Childs, MD, Roger Kurlander, MD, David Stroncek, MD, Hanh Khuu, Deborah Citrin, Marianna Sabatino, MD, Susan Leitman, MD, A. John Barrett, MD

Blood (2010) 116 (21): 2091.

https://doi.org/10.1182/blood.V116.21.2091.2091

Published: 2010

Journal Articles

Selectively T Cell Depleted Allografts From HLA-Matched Sibling Donors Followed by Low-Dose Post Transplant Immunosuppression to Limit Disease Relapse In Patients with Hematological Malignancies

Zachariah A. McIver, DO, Stephan Mielke, MD, Aarthi Shenoy, MD, Vicki Fellows, David Stroncek, MD, Susan Leitman, MD, Richard Childs, MD, Minoo Battiwalla, MD, MS, Eleftheria K. Koklanaris, BS, Janice Haggerty, RN, Bipin N. Savani, MD, Katy Rezvani, A. John Barrett, MD

Blood (2010) 116 (21): 4705.

https://doi.org/10.1182/blood.V116.21.4705.4705

Published: 2010

Journal Articles

Evolution of the Donor T Cell Repertoire In Allogeneic Stem Cell Transplant Recipients In the Second Decade After Transplantation

Robert Q. Le, MD, PhD, J. Joseph Melenhorst, PhD, Brenna Hill, MPhil, Sarfraz Memon, MD, Minoo Battiwalla, MD, MS, Bipin N. Savani, MD, Aarthi Shenoy, MD, Nancy F. Hensel, BS, Eleftheria K. Koklanaris, RN, BS, Keyvan Keyvanfar, BS, Frances T. Hakim, PhD, Daniel C. Douek, MD, PhD, A. John Barrett, MD, FRCP, FRCPath

Blood (2010) 116 (21): 831.

https://doi.org/10.1182/blood.V116.21.831.831

Published: 2010

Journal Articles

Favorable Outcome and Quality of Life in Patients Surviving 5 or More Years After Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies.

Robert Quan Le, MD, PhD, Margaret Bevans, RN, PhD, Bipin N. Savani, MD, Sandra Mitchell, CRNP, PhD, Kate Stringaris, MD, Eleftheria K. Koklanaris, RN, BSN, A. John Barrett, MD

Blood (2009) 114 (22): 3312.

https://doi.org/10.1182/blood.V114.22.3312.3312

Published: 2009

Journal Articles

The Level of Minimal Residual Disease in Primitive Progenitor Cells from CML Patients after Allogeneic Stem Cell Transplantation Is Higher Than after Treatment with Tyrosine Kinase Inhibitors.

Agnes S. M. Yong, MD, PhD, Keyvan Keyvanfar, BS, Rhoda Eniafe, BS, Bipin N. Savani, MD, Katayoun Rezvani, MD, PhD, Aarthi Shenoy, MD, Eleftheria K. Koklanaris, BSN, Laura Musse, MSN, Theresa Donohue, MS, Quan Le, MD, PhD, John M. Goldman, MD, A. John Barrett, MD

Blood (2008) 112 (11): 1107.

https://doi.org/10.1182/blood.V112.11.1107.1107

Published: 2008

NARROW

Phase 1 Trial Of Bone Marrow Stromal Cells (Bone Marrow-derived MSCS) To Treat Tissue Damage In Allogeneic Stem Cell Transplant Recipients: Biological Markers Correlate With Clinical Responses and Survival

Contrast Enhanced Cardiac CT Detects Coronary Artery Disease In 44% Of Asymptomatic Long-Term Adult Allogeneic Stem Cell Transplant Survivors

Post-Transplant Pulmonary Function Abnormalities Normalize in Survivors by the Second Decade After Allogeneic Stem Cell Transplantation

Second Stem Cell Transplantation (SCT) for Relapsed Leukemia Provides Only Modest Prolongation of Survival

Chronic Graft Versus Host Disease (GVHD) Does Not Impact Cardiovascular Risk Factors in Survivors of Allogeneic Hematopoietic Stem Cell Transplantation (SCT) up to the Second Decade Post-Transplant,

Impact of Tyrosine Kinase Inhibitor (TKI) in Chronic Myeloid Leukemia (CML) Relapsing After T Cell Depleted Allogeneic Stem Cell Transplantation (SCT)

Evolution of the donor T-cell repertoire in recipients in the second decade after allogeneic stem cell transplantation

4-Log Ex-Vivo T-Lymphocyte Depleted Myeloablative HLA-Matched Sibling Transplants; a Platform for Adoptive Immunotherapy

Selectively T Cell Depleted Allografts From HLA-Matched Sibling Donors Followed by Low-Dose Post Transplant Immunosuppression to Limit Disease Relapse In Patients with Hematological Malignancies

Evolution of the Donor T Cell Repertoire In Allogeneic Stem Cell Transplant Recipients In the Second Decade After Transplantation

Favorable Outcome and Quality of Life in Patients Surviving 5 or More Years After Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies.

The Level of Minimal Residual Disease in Primitive Progenitor Cells from CML Patients after Allogeneic Stem Cell Transplantation Is Higher Than after Treatment with Tyrosine Kinase Inhibitors.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only